A Look at the Numbers: Cost of Durable Treatments in Retinal Disease
Jayanth Sridhar, MD
Sabin Dang, MD
Reconsidering the Algorithm: Treatment-Resistant DME
Durga Borkar, MD, MMCi
Christina Y. Weng, MD, MBA
A Closer Look at Real-World Strategies for Treatment-Resistant DME
Reconsidering the Algorithm: DME
Clinical Evidence for Durable Treatment of nAMD
Factors to Consider When Thinking About Switching a Patient's ARV Regimen
Sorana Segal-Maurer, MD
Carl Fichtenbaum, MD
Clinical Evidence for Durable Treatment of DME
Reconsidering the Algorithm: nAMD
NASH: An Epidemic with Significant Implications for Managed Care Professionals
October 18, 2023
06:00 PM - 08:00 PM EDT
Zobair M Younossi MD, MPH, FACP, FACG, AGAF, FAASLD
Naim Alkhouri, MD
Kathleen E. Corey, MD, MPH
Real-World Treatment of Retinal Disease
Reducing Retina Treatment Burden in the Real World: Emerging Evidence with Treatment Advances
Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
David Staskin, MD
Roger Dmochowski, MD
Sickle Cell Disease Across the Life Span: What Your Patients Want You to Know
Biree Andemariam, MD
Caroline Freiermuth, MD
Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists
October 22, 2023
07:30 PM - 09:30 PM PDT
Kimberly A. Brown, MD
Mazen Noureddin, MD
Alina M. Allen, MD
HIV and Cardiometabolic Health: What's the Connection?
David Wohl, MD
Cardiometabolic Disease in Patients with HIV: Who's at Greatest Risk?
My Patient Is Stable on ART, But Has Gained 30 Pounds: What Are My Options?
Managing ART for Optimal Cardiometabolic Health
Cardiometabolic Risk in HIV Treatment: Balancing ART Choice and Potential for Weight Gain
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying Prova Education…but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.